Home/Filings/4/0001562180-24-007233
4//SEC Filing

Vos Ellen O'Connor 4

Accession 0001562180-24-007233

CIK 0000926617other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:44 PM ET

Size

8.2 KB

Accession

0001562180-24-007233

Insider Transaction Report

Form 4
Period: 2024-09-30
Transactions
  • Exercise/Conversion

    Common Stock

    2024-09-30+5,31358,052 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-09-305,31315,937 total
    Common Stock (5,313 underlying)
Footnotes (3)
  • [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
  • [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
  • [F3]On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.

Issuer

Aspira Women's Health Inc.

CIK 0000926617

Entity typeother

Related Parties

1
  • filerCIK 0001534357

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:44 PM ET
Size
8.2 KB